Loading...
Biocon Q3 Earnings: Revenue Up 9% But Misses Forecasts; Exceptional Loss Hits Profit
LIVE TV
LOCAL
ENGLISH
For You
Entertainment
National
Sports
Markets
Business & Economy
Lifestyle
World
Astrology & Religion
Technology
Education & Jobs
Auto
Politics
Viral
Opinions
Home
Local
Live TV
Loading more articles...
Biocon Q3: Revenue Up 9%, Misses Estimates; Exceptional Loss Hits Profit
C
CNBC TV18
•
12-02-2026, 21:08
Biocon Q3: Revenue Up 9%, Misses Estimates; Exceptional Loss Hits Profit
•
Biocon reported a mixed Q3 performance, with revenue and operating profit missing street estimates.
•
Net profit rose to ₹143.8 crore, significantly higher than ₹25.1 crore year-on-year, but below CNBC-TV18's estimate of ₹167.5 crore.
•
The company recorded a one-time exceptional loss of ₹293.4 crore during the quarter.
•
Revenue grew 9.2% to ₹4,173 crore, missing the estimated ₹4,556.2 crore.
•
Biocon's board approved acquiring the remaining ~2% stake in Biocon Biologics Limited (BBL), making it a wholly owned subsidiary.
Read Full Article on Cnbc in English
✦
More like this
✦
More like this
Biocon Q3 Profit Multiplies, Revenue Up 9%, But Misses Market Expectations
C
CNBC Awaaz
Biocon Q3 Net Profit Soars 5-Fold to Rs 144 Cr, Driven by Generics & Biosimilars
N
News18
Pharma Q3: Eris, IPCA Soar, Blue Jet Profit Jumps 59.6% Amid Revenue Dip
C
CNBC Awaaz
Biocon acquires Biocon Biosphere, Pharma for ₹315 Cr; Q3 net profit rises to ₹143.8 Cr
C
CNBC TV18
Divi's Labs Q3 Profit Misses Estimates, Revenue Up; Strong Operating Performance
C
CNBC TV18
Jubilant FoodWorks Q3 Profit Jumps to ₹54 Cr, Revenue Up; Misses Estimates
C
CNBC Awaaz